MARCI CLINE: Open Payments
NPI 1609498492 · CAMERON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 26 payments from 12 companies in 2025. Trend: 2023 $395 · 2024 $174 · 2025 $514
Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 8 | $139 |
| ABBVIE INC. | 5 | $120 |
| PFIZER INC. | 4 | $86 |
| MIMEDX Group, Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Astellas Pharma US Inc | 1 | $23 |
| Smith+Nephew, Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: INGREZZA, VRAYLAR, PREVNAR 20, AUSTEDO XR, Veozah, COLLAGENASE SANTYL, NURTEC ODT, Auvelity.
Industry payments across MO — which companies pay providers there.
